Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

Explore the Efficacy and Safety of Once-daily Oral Rivaroxaban for the Prevention of Cardiovascular Events in Subjects With Nonvalvular Atrial Fibrillation Scheduled for Cardioversion

ClinicalTrials.gov ID: NCT01674647

Public ClinicalTrials.gov record NCT01674647. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 21, 2026, 6:26 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Prospective, Randomized, Open-label, Parallel-group, Active-controlled, Multicenter Study Exploring the Efficacy and Safety of Once-daily Oral Rivaroxaban (BAY59-7939) Compared With That of Dose-adjusted Oral Vitamin K Antagonists (VKA) for the Prevention of Cardiovascular Events in Subjects With Nonvalvular Atrial Fibrillation Scheduled for Cardioversion

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

A study for patients with abnormal heart rhythm (atrial fibrillation) who need to undergo cardioversion (procedure to restore normal heart rhythm). The study will compare patients assigned randomly (like flipping a coin) to either Rivaroxaban or vitamin K antagonist (VKA). The study will measure common medical outcomes for this type of patient such as bleeding and stroke.

Study identification

NCT ID
NCT01674647
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Bayer
Industry
Enrollment
1,504 participants

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Oct 2012 (Type not available)
Primary completion
Jan 2014 (Actual)
Completion
Jan 2014 (Actual)
Last update posted
Apr 30, 2015

2012 – 2014

United States locations

U.S. sites
66
U.S. states
23
U.S. cities
61
Facility City State ZIP Site status
Not listed Mobile Alabama 36608 —
Not listed Scottsdale Arizona 85258 —
Not listed East Palo Alto California 94303 —
Not listed El Cajon California 92020 —
Not listed National City California 91950 —
Not listed Sacramento California 95819 —
Not listed Santa Rosa California 95494 —
Not listed Torrance California 90502-2004 —
Not listed New Haven Connecticut 06520 —
Not listed Stamford Connecticut 06905 —
Not listed Wilmington Delaware 19803 —
Not listed Clearwater Florida 33756 —
Not listed Daytona Beach Florida 32117 —
Not listed Deltona Florida 32725 —
Not listed Fort Lauderdale Florida 33308 —
Not listed Fort Lauderdale Florida 33316 —
Not listed Hollywood Florida 33021 —
Not listed Jacksonville Florida 32216 —
Not listed Lakeland Florida 33805 —
Not listed Melbourne Florida 32901 —
Not listed Miami Florida 33135 —
Not listed Orlando Florida 32806 —
Not listed Saint Augustine Florida 32216 —
Not listed Tallahassee Florida 32308 —
Not listed Savannah Georgia 31419 —
Not listed Aurora Illinois 60504 —
Not listed Chicago Illinois 60612 —
Not listed Chicago Illinois 60637 —
Not listed Elk Grove Village Illinois 60007 —
Not listed Joliet Illinois 60435 —
Not listed Rockford Illinois 61107 —
Not listed Annapolis Maryland 21401 —
Not listed Columbia Maryland 21044 —
Not listed Rockville Maryland 20853 —
Not listed Lincoln Nebraska 68516 —
Not listed North Las Vegas Nevada 89086 —
Not listed Bridgewater New Jersey 08807 —
Not listed Manalapan New Jersey 07716 —
Not listed Albuquerque New Mexico 87102 —
Not listed Buffalo New York 14215 —
Not listed New York New York 10013 —
Not listed New York New York 10032 —
Not listed Troy New York 12180 —
Not listed Asheville North Carolina 28805 —
Not listed Cantan Ohio 44708 —
Not listed Cleveland Ohio 44195 —
Not listed Mansfield Ohio 44906 —
Not listed Toledo Ohio 43623 —
Not listed Beaver Pennsylvania 15009 —
Not listed Butler Pennsylvania 16001 —
Not listed Doylestown Pennsylvania 18901 —
Not listed Hershey Pennsylvania 17033 —
Not listed Philadelphia Pennsylvania 19102 —
Not listed Philadelphia Pennsylvania 19141 —
Not listed Rapid City South Dakota 57701 —
Not listed Johnson City Tennessee 37604 —
Not listed Nashville Tennessee 37203 —
Not listed Nashville Tennessee 37232 —
Not listed Austin Texas 78745 —
Not listed Dallas Texas 75231 —
Not listed Fort Sam Houston Texas 78234-6200 —
Not listed Tyler Texas 75701 —
Not listed Layton Utah 84041 —
Not listed Bellingham Washington 98225 —
Not listed Burien Washington 98166 —
Not listed Wausau Wisconsin 54401 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 112 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT01674647, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Apr 30, 2015 · Synced Oct 21, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT01674647 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →